Prostaglandin E2 and gastric acid secretion in man

Area of Science:

• Gastroenterology
• Pharmacology
• Biochemistry

Background:

• Prostaglandins (PGs) are implicated in various physiological processes, including gastric function.
• The specific role of prostaglandin E2 (PGE2) in human gastric acid secretion and its relation to drug-induced gastric bleeding remains incompletely understood.

Purpose of the Study:

• To investigate the synthesis and distribution of PGE2-like substances in the human stomach.
• To determine the effect of PGE2 on gastric acid secretion.
• To explore the mechanism of gastric bleeding induced by aspirin-like drugs.

Main Methods:

• Extraction and measurement of PGE2-like activity in human stomach tissue homogenates and gastric juice.
• Analysis of PGE2 distribution within mucosal layers.
• Assessment of gastric acid secretion changes following indomethacin administration (a PG synthesis inhibitor) and oral PGE2 administration.

Main Results:

• Human stomach tissue demonstrates the capacity to synthesize PGE2, with peak levels found in the upper mucosal layers (0-600 µm).
• PGE2 concentrations in gastric juice are low and do not significantly increase with stimulated secretion.
• Inhibition of PG synthesis led to a slight decrease, not an increase, in acid secretion, and orally administered PGE2 did not inhibit secretion.

Conclusions:

• PGE2 does not appear to play an inhibitory role in human gastric acid secretion.
• Gastric bleeding induced by aspirin-like drugs may be primarily due to PG inhibition-induced vasoconstriction and ischemia, rather than increased acid secretion.